HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

3- sulfoglucuronyl- lactosaminyl- paragloboside

Also Known As:

SGLPG

Networked: 7 relevant articles (0 outcomes, 0 trials/studies)

Bio-Agent Context: Research Results

Experts

1.	Caudie, C: 3 articles (07/2006 - 09/2001)
2.	Petiot, P: 2 articles (07/2006 - 09/2001)
3.	Vial, C: 2 articles (07/2006 - 09/2001)
4.	Antoine, J-C: 1 article (07/2006)
5.	Gonnaud, P-M: 1 article (07/2006)
6.	Jaquet, P: 1 article (07/2006)
7.	Kaygisiz, F: 1 article (07/2006)
8.	Drouet, A: 1 article (06/2006)
9.	Felten, D: 1 article (06/2006)
10.	Giraud, P: 1 article (06/2006)

Related Diseases

1.	Peripheral Nervous System Diseases (PNS Diseases) 07/01/2006 - "[Diagnostic value of autoantibodies to MAG by ELISA Bühlmann in 117 immune-mediated peripheral neuropathies associated with monoclonal IgM to SGPG/SGLPG]." 07/01/2006 - "We selected 117 patients with anti-SGPG/SGLPG monoclonal gammopathy and peripheral neuropathy and a control group of 102 peripheral neuropathies with 24 having IgM high titres of monoclonal IgM anti-ganglioside antibodies. " 09/01/2001 - "Six M-IgM autoantibody activity profiles have been described in correlation with distinct clinical syndromes: - the M-IgM autoantibody activity profile against the carbohydrate epitope common to the glycolipids SGPG and SGLPG and myelin associated glycoprotein (MAG) in chronic demyelinating sensitive and sensorimotor peripheral neuropathies (58 patients, 52%); - the M-IgM autoantibody activity profile against immunodominant GM1 in demyelinating pure motor neuropathies (9 patients, 8%); - the M-IgM autoantibody activity profile against immunodominant disialosylgangliosides in chronic demyelinating sensitive ataxic neuropathies (8 patients, 7%); - the M-IgM autoantibody activity profile against immunodominant GM2 in demyelinating motor polyneuropathies (3 patients, 2.5%); - the M-IgM autoantibody activity profile against immunodominant GD1a in pure motor polyneuropathies (2 patients, 2%); - the M-IgM autoantibody activity profile against immunodominant GT1b and polysialosylgangliosides in one acute polyradiculoneuropathy (1%). "
2.	Paraproteinemias (Monoclonal Gammopathy) 06/01/2006 - "A typically distal and symmetrical, slowly progressive sensorimotor demyelinating neuropathy is caused by monoclonal IgM against myelin-associated glycoprotein (MAG) and SGPG, SGLPG glycolipids in the context of a benign IgM paraproteinemia. " 07/01/2006 - "We selected 117 patients with anti-SGPG/SGLPG monoclonal gammopathy and peripheral neuropathy and a control group of 102 peripheral neuropathies with 24 having IgM high titres of monoclonal IgM anti-ganglioside antibodies. "
3.	Hashimoto Disease (Thyroiditis, Hashimoto) 10/01/1998 - "We reported a case of mononeuropathy multiplex associated with anti-GM1 and -SGLPG antibodies in a patient with ongoing Hashimoto disease. " 10/01/1998 - "[A case of mononeuropathy multiplex associated with anti-GM1 and -SGLPG antibodies in a patient with ongoing Hashimoto disease]."
4.	Hearing Loss (Hearing Impairment) 04/15/1998 - "We found that 37 out of 74 patients of clinically diagnosed autoimmune inner ear disease (30 of sensorineural hearing loss (SNHL) (group I), 14 of vestibular symptoms only (group II), 30 of Menieres symptoms (with both hearing loss and vestibular symptoms) (group III)) showed positive anti-sulfoglucuronosyl lactosaminyl paragloboside (SGLPG) antibody titers (p < 0.001). "
5.	Mononeuropathies (Mononeuritis Multiplex) 10/01/1998 - "We reported a case of mononeuropathy multiplex associated with anti-GM1 and -SGLPG antibodies in a patient with ongoing Hashimoto disease. " 10/01/1998 - "[A case of mononeuropathy multiplex associated with anti-GM1 and -SGLPG antibodies in a patient with ongoing Hashimoto disease]."

Related Drugs and Biologics

1.	sulfate-3-glucuronyl paragloboside
2.	Immunoglobulin M (IgM)
3.	Myelin-Associated Glycoprotein
4.	Glycolipids
5.	Autoantibodies
6.	Antibodies
7.	paragloboside (neolactotetraosylceramide)
8.	Sulfates (Sulfates, Inorganic)
9.	Lipids
10.	Indicators and Reagents (Reagents)